Fiera Capital (Canada)
APLS

Fiera Capital (Canada)’s Apellis Pharmaceuticals APLS Stock Holding History

Fiera Capital (Canada)’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,354,469
Closed -$39.1M – 455
2024
Q3 		$39.1M Sell
1,354,469
-46,721
-3% -$1.73M 0.12% 117
2024
Q2 		$53.7M Buy
1,401,190
+452,753
+48% +$20.5M 0.17% 88
2024
Q1 		$55.7M Buy
948,437
+29,347
+3% +$1.87M 0.16% 91
2023
Q4 		$55M Sell
919,090
-600
-0.1% -$30.4K 0.17% 89
2023
Q3 		$35M Buy
919,690
+391,770
+74% +$17.2M 0.11% 111
2023
Q2 		$48.1M Sell
527,920
-12,462
-2% -$1.08M 0.14% 87
2023
Q1 		$35.6M Buy
+540,382
New +$31.2M 0.11% 109

Other funds holding APLS

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fiera Capital (Canada)'s APLS Position: Q4 2024 in Review

Fiera Capital (Canada) sold out of Apellis Pharmaceuticals (APLS) in Q4 2024, closing a stake of 1,354,469 shares — an estimated $39.1M sold.

Fiera Capital (Canada) first reported a position in APLS in Q1 2023 and held it in 7 quarters. The position peaked at $55.7M in Q1 2024. 260 funds tracked by Wall St. Rank hold APLS as of Q4 2024.

  • Fiera Capital (Canada) reported no remaining Apellis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,354,469 Apellis Pharmaceuticals shares in Q4 2024, an estimated $39.1M.
  • Fiera Capital (Canada) first reported a position in Apellis Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Fiera Capital (Canada)'s Apellis Pharmaceuticals position peaked at $55.7M in Q1 2024.
  • 260 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2024.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2024, filed 29 Jan 2025.